Barrett’s Esophagus: Evaluation and Management
نویسندگان
چکیده
history The patient has no significant past medical history other than being overweight. He drinks 1 glass of wine per day and does not smoke. Family medical history is unremarkable for any malignancies. He does not exercise because he “works all the time” and has gained approximately 22 lb over the last year. The patient describes his heartburn symptom as a substernal “burning” sensation, which occurs approximately 30 minutes after eating and lasts approximately 1 to 2 hours. He was taking omeprazole 20 mg daily with antacids as needed and his symptoms were well controlled on this regimen; however, recently his symptoms have persisted despite these medications, and his dose of omeprazole was increased from 20 mg daily to 40 mg twice daily. This has resulted in only minimal improvement of his symptoms.
منابع مشابه
Barrett’s Esophagus - American Family Physician
managed in the primary care setting. Surveys suggest that approximately 20 percent of U.S. adults have symptoms of GERD at least once a week.4 A subgroup of patients with GERD develop severe complications that include erosive esophagitis, stricture formation, Barrett’s esophagus, and adenocarcinoma of the esophagus. Because Barrett’s esophagus is thought to be associated with the development of...
متن کاملCCR New Strategies New Strategies in Barrett's Esophagus: Integrating Clonal Evolutionary Theory with Clinical Management
Barrett’s esophagus is a condition in which the normal stratified squamous epithelium of the distal esophagus is replaced by intestinal metaplasia. For more than three decades, the prevailing clinical paradigm has been that Barrett’s esophagus is a complication of symptomatic reflux disease that predisposes to esophageal adenocarcinoma. However, no clinical strategy for cancer prevention or ear...
متن کاملMeta-Analysis The Incidence of Esophageal Cancer and High-Grade Dysplasia in Barrett’s Esophagus: A Systematic Review and Meta-Analysis
Barrett’s esophagus is a well-recognized precursor of esophageal adenocarcinoma. Surveillance of Barrett’s esophagus patients is recommended to detect high-grade dysplasia (HGD) or early cancer. Because of wide variation in the published cancer incidence in Barrett’s esophagus, the authors undertook a systematic review and meta-analysis of cancer and HGD incidence in Barrett’s esophagus. Ovid M...
متن کاملEndoscopic work-up of early Barrett's neoplasia.
In recent years, endoscopic therapy of early Bar− rett’s esophagus neoplasia has become a safe and effective alternative to esophagectomy [1 ± 4]. Only patients with high−grade intraepithelial neoplasia (HGIN) or mucosal cancer are eligible for curative endoscopic treatment. Lesions that invade the submucosa are associated with a sig− nificant risk of lymph node metastases and are therefore pre...
متن کاملImpediments to implementation of real-time pathology prediction in Barrett’s esophagus and colorectal polyps
Tools like narrow band imaging (Olympus, Center Valley, Pennsylvania, United States), confocal laser microscopy (Mauna Kea Technologies, Paris, France), and chromoendoscopy (sometimes with magnification) have been used to successfully predict the pathology of diminutive colon polyps [1,2] as well as the presence of dysplasia in Barrett’s esophagus [3–8]. Despite numerous publications demonstrat...
متن کاملPii: S1091-255x(02)00003-3
The glutathione S–transferases (GSTs) are a family of enzymes that play an important role in the prevention of cancer by detoxifying numerous potentially carcinogenic compounds. GSTs conjugate reduced glutathione to a variety of electrophilic and hydrophobic compounds, converting them into more soluble, more easily excretable compounds. Decreased glutathione S–transferase-pi (GSTPI) enzyme acti...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2008